Literature DB >> 27448304

Silencing of TGIF attenuates the tumorigenicity of A549 cells in vitro and in vivo.

Yadong Wang1,2, Teng Pan3, Haiyu Wang4, Li Li4, Jiangmin Li4, Congke Zhang4, Haiyan Yang3.   

Abstract

The aim of this study was to investigate the effects of the silencing of the TG-interacting factor (TGIF) on the tumorigenicity of A549 cells in vitro and in vivo. Stable TGIF-silenced A549 cells were established by infecting shRNA lentiviral particles. Western blotting analysis was used to detect the expression of proteins. Cell cycle was detected by flow cytometry. Soft agar assay and tumor formation assay in nude mice were applied. The silencing of TGIF inhibited A549 cell proliferation, colony formation in vitro, growth of tumor xenograft in vivo, and arrested the cell cycle in the G1 phase. The expression of CDK4, cyclin D1, and phospho-Rb was markedly decreased in the A549-shTGIF cells compared with the A549-shcon cells, and p21 was markedly increased in the A549-shTGIF cells compared with the A549-shcon cells. A lower level of β-Catenin protein expression was observed in the A549-shTGIF cells than that in the A549-shcon cells. The silencing of TGIF attenuates the tumorigenicity of A549 cells in vitro and in vivo.

Entities:  

Keywords:  A549 cell; Cell cycle; TGIF; Tumorigenicity

Mesh:

Substances:

Year:  2016        PMID: 27448304     DOI: 10.1007/s13277-016-5222-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

1.  A Smad transcriptional corepressor.

Authors:  D Wotton; R S Lo; S Lee; J Massagué
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

2.  TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesis.

Authors:  Ming-Zhu Zhang; Olivier Ferrigno; Zhe Wang; Mutsuko Ohnishi; Céline Prunier; Laurence Levy; Mohammed Razzaque; Williams C Horne; Damian Romero; Guri Tzivion; Frédéric Colland; Roland Baron; Azeddine Atfi
Journal:  Cancer Cell       Date:  2015-04-13       Impact factor: 31.743

3.  TGIF1 promoted the growth and migration of cancer cells in nonsmall cell lung cancer.

Authors:  Guo Xiang; Yang Yi; He Weiwei; Wu Weiming
Journal:  Tumour Biol       Date:  2015-06-24

Review 4.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

5.  TGIF inhibits retinoid signaling.

Authors:  Laurent Bartholin; Shannon E Powers; Tiffany A Melhuish; Samuel Lasse; Michael Weinstein; David Wotton
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

6.  Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours.

Authors:  Jürgen Borlak; Tatiana Meier; Roman Halter; Reinhard Spanel; Katharina Spanel-Borowski
Journal:  Oncogene       Date:  2005-03-10       Impact factor: 9.867

7.  Embryonic fibroblasts from mice lacking Tgif were defective in cell cycling.

Authors:  Lynn Mar; Pamela A Hoodless
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 8.  Cell cycle regulation and its aberrations in human lung carcinoma.

Authors:  Yoh Dobashi
Journal:  Pathol Int       Date:  2005-03       Impact factor: 2.534

9.  Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer.

Authors:  Mónica Castro; Laura Grau; Patricia Puerta; Liliana Gimenez; Julio Venditti; Silvia Quadrelli; Marta Sánchez-Carbayo
Journal:  J Transl Med       Date:  2010-09-17       Impact factor: 5.531

10.  Inhibitory role of TGIF in the As2O3-regulated p21 WAF1/CIP1 expression.

Authors:  Zi-Miao Liu; Huei-Sheng Huang
Journal:  J Biomed Sci       Date:  2008-01-22       Impact factor: 8.410

View more
  9 in total

1.  TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness.

Authors:  Renle Du; Wenzhi Shen; Yi Liu; Wenjuan Gao; Wei Zhou; Jun Li; Shuangtao Zhao; Chong Chen; Yanan Chen; Yanhua Liu; Peiqing Sun; Rong Xiang; Yi Shi; Yunping Luo
Journal:  Signal Transduct Target Ther       Date:  2019-12-13

2.  The Chinese Medicine, Shezhi Huangling Decoction, Inhibits the Growth and Metastasis of Glioma Cells via the Regulation of miR-1298-5p/TGIF1 Axis.

Authors:  Xiaoqian Liu; Jianfeng Ju; Qun Liu; Zongmin Zhu; Chunxia Liu
Journal:  Cancer Manag Res       Date:  2020-07-13       Impact factor: 3.989

3.  STIM1 silencing inhibits the migration and invasion of A549 cells.

Authors:  Yadong Wang; Haiyu Wang; Teng Pan; Li Li; Jiangmin Li; Haiyan Yang
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

4.  Elevated expression of STIM1 is involved in lung tumorigenesis.

Authors:  Yadong Wang; Haiyu Wang; Li Li; Jiangmin Li; Teng Pan; Ding Zhang; Haiyan Yang
Journal:  Oncotarget       Date:  2016-12-27

5.  TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness.

Authors:  Renle Du; Wenzhi Shen; Yi Liu; Wenjuan Gao; Wei Zhou; Jun Li; Shuangtao Zhao; Chong Chen; Yanan Chen; Yanhua Liu; Peiqing Sun; Rong Xiang; Yi Shi; Yunping Luo
Journal:  Signal Transduct Target Ther       Date:  2019-12-13

6.  Constructing gene regulatory networks using epigenetic data.

Authors:  Abhijeet Rajendra Sonawane; Dawn L DeMeo; John Quackenbush; Kimberly Glass
Journal:  NPJ Syst Biol Appl       Date:  2021-12-09

7.  Knockdown of TGIF attenuates the proliferation and tumorigenicity of EC109 cells and promotes cisplatin-induced apoptosis.

Authors:  Yadong Wang; Teng Pan; Li Li; Haiyu Wang; Jiangmin Li; Ding Zhang; Haiyan Yang
Journal:  Oncol Lett       Date:  2017-09-21       Impact factor: 2.967

8.  Silencing of TGIF sensitizes MDA-MB-231 human breast cancer cells to cisplatin-induced apoptosis.

Authors:  Teng Pan; Tingting Mao; Haiyan Yang; Haiyu Wang; Yadong Wang
Journal:  Exp Ther Med       Date:  2018-01-19       Impact factor: 2.447

9.  Overexpression of SIRT6 attenuates the tumorigenicity of hepatocellular carcinoma cells.

Authors:  Yadong Wang; Teng Pan; Haiyu Wang; Li Li; Jiangmin Li; Ding Zhang; Haiyan Yang
Journal:  Oncotarget       Date:  2017-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.